<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05615649</url>
  </required_header>
  <id_info>
    <org_study_id>G220197</org_study_id>
    <nct_id>NCT05615649</nct_id>
  </id_info>
  <brief_title>Expanded Indications in the Pediatric BONEBRIDGE Population</brief_title>
  <official_title>Expanded Indications in the Pediatric BONEBRIDGE Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Med-El Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Med-El Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess safety and efficacy of the MED-EL BONEBRIDGE Bone Conduction Implant&#xD;
      in children under 12 years old with conductive or mixed hearing loss.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective multicenter IDE study will include 36 children implanted with the MED-EL&#xD;
      BONEBRIDGE system at six academic medical centers across the US.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2023</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">June 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional gain</measure>
    <time_frame>Up to six (6) months post-activation</time_frame>
    <description>Postoperative improvement in aided soundfield thresholds compared to preoperative unaided soundfield thresholds</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Up to six (6) months post-activation</time_frame>
    <description>Number and proportion of subjects experiencing serious device- and surgery-related adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Word recognition score</measure>
    <time_frame>Up to six (6) months post-activation</time_frame>
    <description>Postoperative improvement on aided Consonant-Nucleus-Consonant (CNC) Words compared to preoperative unaided CNC word score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unaided bone-conduction pure-tone average (BC-PTA)</measure>
    <time_frame>Up to three (3) months post-activation</time_frame>
    <description>Postoperative shift in unaided bone-conduction BC-PTA compared to preoperative unaided BC-PTA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-intervention quality-of-life questionnaire</measure>
    <time_frame>Up to six (6) months post-activation</time_frame>
    <description>Total and subscale scores on Glasgow Children's Benefit Inventory</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Hearing Loss, Conductive</condition>
  <condition>Hearing Loss, Mixed</condition>
  <arm_group>
    <arm_group_label>Study procedure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This single-arm, repeated-measures study includes study visits at baseline, surgery, device activation, and at 1, 3, 6, and 12 months post-activation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MED-EL BONEBRIDGE Bone Conduction Implant</intervention_name>
    <description>Subjects will be implanted with the MED-EL BONEBRIDGE Bone Conduction Implant System. Subjects will be fit with the appropriate external audio sound processor.</description>
    <arm_group_label>Study procedure</arm_group_label>
    <other_name>BCI 602</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Under 12 years of age&#xD;
&#xD;
          -  Unaided bone-conduction thresholds at 0.5, 1, 2, and 4 kHz better than or equal to 45&#xD;
             dB HL in the ear to be implanted&#xD;
&#xD;
          -  Sufficient air-bone gap (ABG) at in the ear to be implanted&#xD;
&#xD;
          -  HRCT scan that confirms sufficient bone quantity and quality to recess and fix the BCI&#xD;
             in the ear to be implanted&#xD;
&#xD;
          -  Developmental, cognitive, and language skills needed to provide an unaided speech&#xD;
             recognition threshold (SRT) in quiet with English spondees&#xD;
&#xD;
          -  Prior experience with acoustic or bone conduction hearing aids, unless candidate is&#xD;
             unable to wear amplification for medical reasons&#xD;
&#xD;
          -  Parental commitment to comply with all study procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children under 3 years (36 months) of age&#xD;
&#xD;
          -  Chronic or non-revisable vestibular or balance disorders&#xD;
&#xD;
          -  Abnormally progressive hearing loss&#xD;
&#xD;
          -  Prior use of a hearing implant in the ear to be implanted&#xD;
&#xD;
          -  Current/ongoing use of a hearing implant in the contralateral/non-implant ear&#xD;
&#xD;
          -  Evidence that hearing loss is retrocochlear in origin&#xD;
&#xD;
          -  Medical condition that contraindicates implant surgery or anesthesia&#xD;
&#xD;
          -  Skin or scalp condition precluding use of external audio processor&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>MED-EL Corporation</last_name>
    <phone>1-888-633-3524</phone>
    <email>research.us@medel.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Colorado Health/Children's Hospital of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Sarah Gitomer, MD</last_name>
      <email>sarah.gitomer@childrenscolorado.org</email>
    </contact>
    <contact_backup>
      <last_name>Kristi Engle-Folchert</last_name>
      <email>KRISTI.ENGLEFOLCHERT@CUANSCHUTZ.EDU</email>
    </contact_backup>
    <investigator>
      <last_name>Sarah Gitomer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kirsten Adkisson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Hillary Snapp, AuD, PhD</last_name>
      <email>HSnapp@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Hillary Snapp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Newark/Rutgers New Jersey Medical School</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Robert Jyung, MD</last_name>
      <email>jyungrw@njms.rutgers.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Jyung, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27517</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Morgan Selleck, MD</last_name>
      <email>anne_selleck@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Anne Selleck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caitlin Sapp</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University/Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Oliver Adunka, MD</last_name>
      <email>oliver.adunka@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Oliver Adunka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah Health/Primary Children's Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Neil S Patel, MD</last_name>
      <email>neil.patel@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Neil S Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>November 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>January 26, 2023</last_update_submitted>
  <last_update_submitted_qc>January 26, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Hearing Loss, Conductive</mesh_term>
    <mesh_term>Hearing Loss, Mixed Conductive-Sensorineural</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

